Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the indole and heteroaromatic compound classes. It is catalogued as an experimental molecule in chemical and pharmacological databases but does not have an established clinical use or approved indication. Its mechanism of action and biological targets are not described in public sources. The structure features an indole core linked via a propanamine chain to a substituted pyridine–pyrazolopyridine moiety, suggesting potential for kinase or receptor interaction; however, no specific activity has been reported in the literature or drug databases as of June 2025.[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2S)-1-(6H-indol-3-yl)-3-{[5-(7H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy}propan-2-amine.